Abstract-The effects of long-term dosing with acetyl-L-carnitine (ALC) were examined in aged rats, and they were compared with those in young rats. ALC significantly reduced the !ipofuscin deposition in the brain of aged rats. Emotional parameters such as locomotor activity and rearing behavior are lower in aged rats than in young rats, and these behaviors decreased in both age groups during the experiments.
ALC diminished the decrease of these emotional behaviors, especially in rearing behavior in the aged rats. Furthermore, ALC had no effect on body weight gain. These results might reflect one of the main beneficial pharmacological mechanisms of ALC in clinical use.
Lipofuscin is known to increase in various organs with aging in humans (1-3) and rodents (4-7), and it has been named "age pigment". Although 
Materials and Methods

Animals:
Male Fischer rats, Shizuoka Agricultural Cooperative Association for Laboratory Animals, (2 and 20 months old, at the start of the experiments) were used. All animals were housed 2 or 3 per cage and given free access to food and water; the light-dark cycle was set at 12 hr.
Drugs: ALC was dissolved in water and given doses of 50 and 100 mg/kg/day for 3 months as drinking water. The drug con centration was checked every week by measuring body weight and volume of drinking water taken for a week.
Histochemical pharmacology: The animals were decapitated after the experiments, and the frontal cortex, hippocampus and nucleus oliva were dissected out according to the method of Glowinski and Iversen (20) . Brain tissues were fixed in 10% buffered neutral formalin for 48 hr or more, embedded in paraffin, and sectioned at 3 ,em. The sections were deparaffinated in 100% xylol for 15 min, and the sections were mounted unstained in a low-fluorescence mounting medium (Entellan, Merck). Lipofuscin de position in each nerve cell was observed by UV (365 nm)-excited autofluorescence using a fluorescence microscope equipped with a microscopic measuring light (Type S-RFL P1, Nihon Kohgaku Co., Ltd.) at 420 nm over. The emission from HG-HBO 100 mercury source (Toshiba Co., Ltd.), passed through a UV-2A filter, was used to excite the tissue fluorescence, and the total magni tude was 200X. The instrument was calibrated by considering "0" the value obtained by measuring tissue fluorescence back ground within a circular area of 5 ,em in diameter, delimited by a diaphragm. In this study, lipofuscin was considered to be any intra cellar granules exhibiting blue-yellow intrinsic fluorescence. Thirty nerve cells in the frontal cortex (the 5th layer), hippocampus and nucleus oliva were observed by the blind method. The intensity of autofluorescence was indicated as the average values of 30 nerve cells. Fig. 1 . Lipofuscin deposition in the hippocampus of 5-month-old rats. Lipofuscin deposition was scarcely seen at the nuclear periphery in nerve cells. Lipofuscin deposition was observed by UV-excited autofluorescence intensity (see Materials and Methods).
Autofluorescence was 570x.
Behavioral pharmacology: Locomotor ac tivity was measured using a BTA-1 (Muro machi Kikai Co., Ltd.), which is a high density, optical beam animal movement monitor with 48 infrared beams crossing the monitored area (50X50 cm), with X and Y axis coordinates of 24 and 24, respectively. Thus the position of the animal could be analyzed by the X and Y beams at any time. The rearing behavior was also traced by the BTA-1 with 24 vertical sensor beams set 14 cm above the floor. Each animal was taken out from his home cage. Immediately after the animal was placed in the BTA-1, locomotor activity and rearing behavior was measured every 5 min for 30 min at 2 or 3 days before dosing and at 1 week and 1, 2 and 3 months after the start of dosing. Locomotor activity within the first 10 min was excluded in the data analysis to keep the effects of habi tutation to a minimum. The experiments were carried out from 9:30 A.M. to 5:30 P.M.
Statistics: Statistical analysis were per formed by Dunnett's multiple comparisons (21). Autofluorescence was 570x. 
Results
Histochemical pharmacology:
The effect of ALC on lipofuscin deposition is shown in Figs. 1, 2 and 3 and Table 1 . In young rats, lipofuscin deposition in the nerve cells was scarcely observed, whereas in the aged rats, a considerable amount of lipofuscin was found in the frontal cortex, hippocampus and nucleus oliva. ALC, at a dose of 100 mg/ kg/day, reduced lipofuscin deposition dose dependently by 38% in the frontal cortex and by 45% in the hippocampus, but only reduced it by 7% in the nucleus oliva. ALC at a dose of 50 mg/kg/day significantly reduced lipo fuscin deposition by 12% in the hippocampus.
Behavioral pharmacology:
The effects of ALC on locomotor activity and rearing behavior are shown in Table 2 . The young rats were more active than aged rats in both behaviors, and both behaviors decreased age dependently during the experiments. ALC tended to diminish the decrease of locomotor activity and number of rearings during the experiment in aged rats. These effects of ALC were seen after 1 month or more. ALC had no effects on locomotor activity and number of rearings in the young rats.
Body weight gain: The effects of ALC on body weight gain is shown in Table 3 . ALC had no effect on body weight gain in young or aged rats. increase in elderly animals (1-3) and man (4 7), and our results agreed with this obser vation. Lipofuscin is thought to have an injurious effect on the brain functions, that is, it is supposed to reduce the protein syn theses in nerve cells (3) and axonal trans ports (8), although how this is done is not known. ALC reduced lipofuscin deposition dose-dependently in the various regions of the brain, and this reduction was especially strong in the frontal cortex and hippocampus in aged rats, although the mechanisms are also unknown. This effect of ALC is inter esting since the frontal cortex and hip pocampus, which are cholinergic neuron rich sites, is supposed to be related to the memory and emotion, and ALC is a cholinomimetic drug. Furthermore, ALC is used for treatment of dementia with memory and emotion deficiencies (14) (15) (16) (17) (18) .
However, we have no more results to connect these directly. The lipofuscin seems to deposit easily in the nucleus oliva even in young rats as shown in Table 1 . This might reflect the low effects of ALC in this site of aged rats. Anyway, our findings suggest that the lipofuscin content reducing effect of ALC could play a protective role against aging of the brain. In this study, it is not clear whether ALC has inhibited the lipofuscin deposition or ALC has reduced the lipofuscin which has been already deposited, since the lipofuscin content in 20-month-old rats was not examined. Further experiments will be necessary to elucidate this point.
The young rats were more active in locomotor activity and rearing behavior; although these two behaviors decreased Table 3 .
Effect of acetyl-L-carnitine on body weight of rats during the experiments, these decreases would not have been due to habituation to the experimental circumstances since the measuring points were so long, and in the non-treated groups, the decline curves tended to be age-dependent, but habituation could not be excluded completely. ALC tended to diminish the decrease in locomotor activity and number of rearings in only the aged rats. The locomotor and rearing be haviors are thought to be representative emotional behaviors in animals (22, 23) . Therefore, these diminishing effects in the aged rats might suggest that ALC can be clinically used to improve the emotional disturbance in elderly people. ALC did not affect body weight gain, and this might reflect one of its excellent properties; that is, this drug has low toxicity.
In conclusion, since ALC is mainly used in elderly patients, our results on the phar macological mechanisms of ALC may be beneficial for understanding of its clinical effects.
